These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21063687)

  • 21. Illicit drugs in the environment.
    Zuccato E; Castiglioni S
    Philos Trans A Math Phys Eng Sci; 2009 Oct; 367(1904):3965-78. PubMed ID: 19736230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impacts of emerging organic contaminants on freshwater resources: review of recent occurrences, sources, fate and effects.
    Pal A; Gin KY; Lin AY; Reinhard M
    Sci Total Environ; 2010 Nov; 408(24):6062-9. PubMed ID: 20934204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiresidue method for the analysis of emerging contaminants in wastewater by ultra performance liquid chromatography-time-of-flight mass spectrometry.
    Nurmi J; Pellinen J
    J Chromatogr A; 2011 Sep; 1218(38):6712-9. PubMed ID: 21840011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potential Upstream Strategies for the Mitigation of Pharmaceuticals in the Aquatic Environment: a Brief Review.
    Blair BD
    Curr Environ Health Rep; 2016 Jun; 3(2):153-60. PubMed ID: 27068434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of polar drug residues in sewage and surface water applying liquid chromatography-tandem mass spectrometry.
    Zuehlke S; Duennbier U; Heberer T
    Anal Chem; 2004 Nov; 76(22):6548-54. PubMed ID: 15538775
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occurrence, partition and removal of pharmaceuticals in sewage water and sludge during wastewater treatment.
    Jelic A; Gros M; Ginebreda A; Cespedes-Sánchez R; Ventura F; Petrovic M; Barcelo D
    Water Res; 2011 Jan; 45(3):1165-76. PubMed ID: 21167546
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Occurrence, fate and effects of pharmaceutical substances in the environment--a review.
    Halling-Sørensen B; Nors Nielsen S; Lanzky PF; Ingerslev F; Holten Lützhøft HC; Jørgensen SE
    Chemosphere; 1998 Jan; 36(2):357-93. PubMed ID: 9569937
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Occurrence and reductions of pharmaceuticals and personal care products and estrogens by municipal wastewater treatment plants in Ontario, Canada.
    Lishman L; Smyth SA; Sarafin K; Kleywegt S; Toito J; Peart T; Lee B; Servos M; Beland M; Seto P
    Sci Total Environ; 2006 Aug; 367(2-3):544-58. PubMed ID: 16697441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada.
    Comeau F; Surette C; Brun GL; Losier R
    Sci Total Environ; 2008 Jun; 396(2-3):132-46. PubMed ID: 18377954
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pollution pathways of pharmaceutical residues in the aquatic environment on the island of Mallorca, Spain.
    Rodríguez-Navas C; Björklund E; Bak SA; Hansen M; Krogh KA; Maya F; Forteza R; Cerdà V
    Arch Environ Contam Toxicol; 2013 Jul; 65(1):56-66. PubMed ID: 23440447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Do pharmaceuticals reach and affect the aquatic ecosystems in Brazil? A critical review of current studies in a developing country.
    Quadra GR; Oliveira de Souza H; Costa RD; Fernandez MA
    Environ Sci Pollut Res Int; 2017 Jan; 24(2):1200-1218. PubMed ID: 27734317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmaceutical compounds in the wastewater process stream in Northwest Ohio.
    Spongberg AL; Witter JD
    Sci Total Environ; 2008 Jul; 397(1-3):148-57. PubMed ID: 18396321
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Occurrence, sources, and fate of pharmaceuticals in aquatic environment and soil.
    Li WC
    Environ Pollut; 2014 Apr; 187():193-201. PubMed ID: 24521932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selected analytical challenges in the determination of pharmaceuticals in drinking/marine waters and soil/sediment samples.
    Białk-Bielińska A; Kumirska J; Borecka M; Caban M; Paszkiewicz M; Pazdro K; Stepnowski P
    J Pharm Biomed Anal; 2016 Mar; 121():271-296. PubMed ID: 26818066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Occurrence, fate and transformation of emerging contaminants in water: An overarching review of the field.
    Wilkinson J; Hooda PS; Barker J; Barton S; Swinden J
    Environ Pollut; 2017 Dec; 231(Pt 1):954-970. PubMed ID: 28888213
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Occurrence and fate of pharmaceuticals in wastewater treatment plants and rivers in Korea.
    Sim WJ; Lee JW; Oh JE
    Environ Pollut; 2010 May; 158(5):1938-47. PubMed ID: 19913963
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Illicit drugs and pharmaceuticals in the environment--forensic applications of environmental data, Part 2: Pharmaceuticals as chemical markers of faecal water contamination.
    Kasprzyk-Hordern B; Dinsdale RM; Guwy AJ
    Environ Pollut; 2009 Jun; 157(6):1778-86. PubMed ID: 19299056
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast.
    Gómez MJ; Martínez Bueno MJ; Lacorte S; Fernández-Alba AR; Agüera A
    Chemosphere; 2007 Jan; 66(6):993-1002. PubMed ID: 16962638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Newly Designed Water Treatment Systems for Hospital Effluent].
    Azuma T
    Yakugaku Zasshi; 2018; 138(3):289-296. PubMed ID: 29503418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Flow-injection analysis as a tool for determination of pharmaceutical residues in aqueous environment.
    Trojanowicz M
    Talanta; 2012 Jul; 96():3-10. PubMed ID: 22817920
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.